Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • GLAXOSMITHKLINE PLC Financial Overview

  • Income Statement: GSK

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 44.86 B 45.61 B -750.50 M -1.67%
    Gross Profit 33.71 B 34.77 B -1.06 B -3.14%
    Net Income Before Extra Items/Preferred Div 8.48 B 10.47 B -1.99 B -23.49%
    Operating Income 14.22 B 14.97 B -752.85 M -5.30%
  • Cash Flow: GSK

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -6.04 B -2.91 B -3.13 B 51.88%
    Net Cash Flow - Investing 4.40 B 6.56 B -2.17 B -49.29%
    Net Cash Flow/Operating Activities 12.54 B 12.13 B 407.99 M 3.25%
  • Balance Sheet: GSK

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 53.48 B 57.16 B -3.68 B -6.88%
    Total Liabilities 41.34 B 37.49 B 3.84 B 9.29%
    Shareholders Equity 11.58 B 19.05 B -7.48 B -64.57%
  • Key Ratios / Statistics: GSK

    • Valuation

      Price/Earnings (TTM) 11.42
      Price/Sales (TTM) 2.16
      Price/Book (MRQ) 6.90
      Price/Cash Flow (TTM) 9.09
    • Profitability

      Gross Margin 75.14
      Operating Margin 31.69
      Profit Margin 18.90
    • Dividends

      Dividend Paid (TTM) 1.85
      Payout Ratio % (TTM) 58.60
    • Financial Strength

      Quick Ratio (MRQ) 1.29
      Current Ratio (MRQ) 1.56
      Long Term Debt-to-Equity (MRQ) 162.02
    • Management Effectiveness

      Return on Equity (TTM) 57.35
      Return on Assets (TTM) 14.25
      Return on Investments (TTM) 25.01